Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis
出版年份 2023 全文链接
标题
Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis
作者
关键词
-
出版物
European Journal of Internal Medicine
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-08-28
DOI
10.1016/j.ejim.2023.08.020
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF
- (2023) Josephine Harrington et al. CIRCULATION
- Correct dosing, adherence and persistence of DOACs in atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis
- (2023) Subo Emanuel et al. Open Heart
- Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse
- (2022) Nikolaos Ktenopoulos et al. Frontiers in Bioscience - Scholar
- A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
- (2022) Holger Reinecke et al. CIRCULATION
- Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
- (2022) Sean D. Pokorney et al. CIRCULATION
- 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
- (2021) Jan Steffel et al. EUROPACE
- Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study
- (2021) Yi-Cheng Lin et al. PLoS One
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Multitargeted interventions to reduce dialysis-induced systemic stress
- (2021) Bernard Canaud et al. Clinical Kidney Journal
- Rivaroxaban versus apixaban in non‐valvular atrial fibrillation patients with end‐stage renal disease or receiving dialysis
- (2020) Benjamin Miao et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease
- (2019) Jeffrey T. Ha et al. ANNALS OF INTERNAL MEDICINE
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
- (2019) An S. De Vriese et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States
- (2018) Konstantinos C. Siontis et al. CIRCULATION
- Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
- (2018) Austin Hu et al. SEMINARS IN NEPHROLOGY
- Warfarin and Vascular Calcification
- (2016) Timothy J. Poterucha et al. AMERICAN JOURNAL OF MEDICINE
- Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
- (2016) Clapton Dias et al. AMERICAN JOURNAL OF NEPHROLOGY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
- (2015) An S. De Vriese et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
- (2015) Xiaoli Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis
- (2012) D. Zimmerman et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Bleeding and thrombotic complications of kidney disease
- (2011) Sue Pavord et al. BLOOD REVIEWS
- The Increasing Prevalence of Atrial Fibrillation among Hemodialysis Patients
- (2011) W. C. Winkelmayer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More